NovaPoint Capital’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.43M Buy
58,432
+3,963
+7% +$100K 0.31% 68
2026
Q2
$1.4M Buy
54,469
+5,487
+11% +$141K 0.29% 72
2026
Q1
$1.27M Buy
+48,982
New +$1.28M 0.32% 72
2025
Q4
– Sell
-41,000
Closed -$1.08M – 106
2025
Q3
$1.08M Buy
41,000
+4,008
+11% +$104K 0.26% 76
2025
Q2
$958K Buy
36,992
+774
+2% +$19.6K 0.29% 67
2025
Q1
$926K Buy
+36,218
New +$916K 0.29% 75

Other funds holding IBDY

NovaPoint Capital's IBDY Position: Q3 2026 in Review

NovaPoint Capital increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 7.3% in Q3 2026, buying an estimated $100K and bringing the position to 58,432 shares worth $1.43M. The position accounts for 0.31% of the portfolio, ranked #68.

NovaPoint Capital first reported a position in IBDY in Q1 2025 and has held it in 6 quarters since. 54 funds tracked by Wall St. Rank hold IBDY as of Q3 2026.

  • NovaPoint Capital held 58,432 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $1.43M as of Q3 2026.
  • NovaPoint Capital bought 3,963 iShares iBonds Dec 2033 Term Corporate ETF shares in Q3 2026, an estimated $100K.
  • iShares iBonds Dec 2033 Term Corporate ETF made up 0.31% of NovaPoint Capital's portfolio in Q3 2026, its #68 holding.
  • NovaPoint Capital first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • 54 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q3 2026.

Based on NovaPoint Capital's 13F filing for Q3 2026, filed 22 Oct 2026.